Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Plos One|December 3, 2010
IL-17A/F-signaling does not contribute to the initial phase of mucosal inflammation triggered by S. TyphimuriumPascal Songhet, Manja Barthel, Till A Röhn, et al.Antiviral Research|May 13, 2019
Toll-like receptor 5 agonist flagellin reduces influenza A virus replication independently of type I interferon and interleukin 22 and improves antiviral efficacy of oseltamivirAnne-France Georgel, Delphine Cayet, Andrés Pizzorno, et al.Immunobiology|June 24, 2015
Lactate and short chain fatty acids produced by microbial fermentation downregulate proinflammatory responses in intestinal epithelial cells and myeloid cellsCarolina Iraporda, Agustina Errea, David E Romanin, et al.Chembiochem : a European Journal of Chemical Biology|February 7, 2025
Mutagenesis to Orient Conjugation and Preserve Self-adjuvant Properties of Flagellin in ConjugatesLaura Laneque, Annie Lambert, Delphine Cayet, et al.Vaccine|May 25, 2015
Indirect Toll-like receptor 5-mediated activation of conventional dendritic cells promotes the mucosal adjuvant activity of flagellin in the respiratory tractDelphine Fougeron, Laurye Van Maele, Pascal Songhet, et al.Plos One|October 22, 2013
NADPH oxidase deficient mice develop colitis and bacteremia upon infection with normally avirulent, TTSS-1- and TTSS-2-deficient Salmonella TyphimuriumBoas Felmy, Pascal Songhet, Emma Marie Caroline Slack, et al.Frontiers in Immunology|January 14, 2017
Local Treatment with Lactate Prevents Intestinal Inflammation in the TNBS-Induced Colitis ModelCarolina Iraporda, David E Romanin, Ana A Bengoa, et al.Vaccine|April 5, 2026
Toll-like receptor 5 agonist is a potent adjuvant for intradermal vaccinationJean-Claude Sirard, Delphine Cayet, Delphine Fougeron, et al.Antimicrobial Agents and Chemotherapy|October 31, 2024
Targeted delivery of flagellin by nebulization offers optimized respiratory immunity and defense against pneumococcal pneumoniaMara Baldry, Charlotte Costa, Yasmine Zeroual, et al.Vaccine|December 26, 2018
Recombinant flagellins with deletions in domains D1, D2, and D3: Characterization as novel immunoadjuvantsMarina E Biedma, Delphine Cayet, Julien Tabareau, et al.Pageof 3